Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
25952 | 267 | 49.4 | 92% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
307 | 3 | INTEGRIN//ALPORT SYNDROME//LAMININ | 40384 |
683 | 2 | INTEGRIN//FOCAL ADHESION KINASE//TENASCIN C | 13145 |
25952 | 1 | CAM DR//CELL ADHESION MEDIATED DRUG RESISTANCE//RECEPTOR BIOL TUMOR METASTASIS | 267 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CAM DR | authKW | 920351 | 5% | 62% | 13 |
2 | CELL ADHESION MEDIATED DRUG RESISTANCE | authKW | 544904 | 3% | 53% | 9 |
3 | RECEPTOR BIOL TUMOR METASTASIS | address | 346545 | 4% | 30% | 10 |
4 | EM DR | authKW | 228729 | 1% | 100% | 2 |
5 | EXPT THER EUT ONCOL SCI | address | 152485 | 1% | 67% | 2 |
6 | NON HODGKINS LYMPHOMAS NHL | authKW | 152485 | 1% | 67% | 2 |
7 | ADHESION MOLECULES HUMAN | authKW | 114364 | 0% | 100% | 1 |
8 | ALL IRELAND NCI CANC CONSORTIUM | address | 114364 | 0% | 100% | 1 |
9 | BEAD QUANTIFICATION | authKW | 114364 | 0% | 100% | 1 |
10 | CANC CAMPAIGN MOL CELLULAR PHARMACOL GRP | address | 114364 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 2975 | 54% | 0% | 145 |
2 | Hematology | 1304 | 22% | 0% | 58 |
3 | Cell Biology | 192 | 15% | 0% | 41 |
4 | Pharmacology & Pharmacy | 91 | 13% | 0% | 35 |
5 | Medicine, Research & Experimental | 52 | 6% | 0% | 17 |
6 | Biochemistry & Molecular Biology | 28 | 13% | 0% | 35 |
7 | Genetics & Heredity | 14 | 4% | 0% | 12 |
8 | Pathology | 4 | 2% | 0% | 5 |
9 | Microscopy | 2 | 0% | 0% | 1 |
10 | Transplantation | 1 | 1% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | RECEPTOR BIOL TUMOR METASTASIS | 346545 | 4% | 30% | 10 |
2 | EXPT THER EUT ONCOL SCI | 152485 | 1% | 67% | 2 |
3 | ALL IRELAND NCI CANC CONSORTIUM | 114364 | 0% | 100% | 1 |
4 | CANC CAMPAIGN MOL CELLULAR PHARMACOL GRP | 114364 | 0% | 100% | 1 |
5 | CCA 1 38 | 114364 | 0% | 100% | 1 |
6 | FAIRMONT STATE | 114364 | 0% | 100% | 1 |
7 | H LEE MOFFITT CANC TAMPA | 114364 | 0% | 100% | 1 |
8 | LEUKEMIA MYELOMA | 114364 | 0% | 100% | 1 |
9 | MALIGNANT HEMATOL CHEM BIOL | 114364 | 0% | 100% | 1 |
10 | MED ONCOL MEDJEROME LIPPER MULTIPLE MY | 114364 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DRUG RESISTANCE UPDATES | 85264 | 7% | 4% | 19 |
2 | CURRENT SIGNAL TRANSDUCTION THERAPY | 2104 | 1% | 1% | 2 |
3 | BLOOD CANCER JOURNAL | 1547 | 1% | 1% | 2 |
4 | LEUKEMIA | 1503 | 4% | 0% | 10 |
5 | LEUKEMIA & LYMPHOMA | 1208 | 3% | 0% | 9 |
6 | LEUKEMIA RESEARCH | 1201 | 3% | 0% | 8 |
7 | JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY | 799 | 1% | 0% | 2 |
8 | ONCOGENE | 752 | 4% | 0% | 11 |
9 | MOLECULAR CANCER THERAPEUTICS | 695 | 2% | 0% | 5 |
10 | TUMOR BIOLOGY | 457 | 2% | 0% | 5 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CAM DR | 920351 | 5% | 62% | 13 | Search CAM+DR | Search CAM+DR |
2 | CELL ADHESION MEDIATED DRUG RESISTANCE | 544904 | 3% | 53% | 9 | Search CELL+ADHESION+MEDIATED+DRUG+RESISTANCE | Search CELL+ADHESION+MEDIATED+DRUG+RESISTANCE |
3 | EM DR | 228729 | 1% | 100% | 2 | Search EM+DR | Search EM+DR |
4 | NON HODGKINS LYMPHOMAS NHL | 152485 | 1% | 67% | 2 | Search NON+HODGKINS+LYMPHOMAS+NHL | Search NON+HODGKINS+LYMPHOMAS+NHL |
5 | ADHESION MOLECULES HUMAN | 114364 | 0% | 100% | 1 | Search ADHESION+MOLECULES+HUMAN | Search ADHESION+MOLECULES+HUMAN |
6 | BEAD QUANTIFICATION | 114364 | 0% | 100% | 1 | Search BEAD+QUANTIFICATION | Search BEAD+QUANTIFICATION |
7 | CHEMOTHERAPY AND SCLC | 114364 | 0% | 100% | 1 | Search CHEMOTHERAPY+AND+SCLC | Search CHEMOTHERAPY+AND+SCLC |
8 | CMDR | 114364 | 0% | 100% | 1 | Search CMDR | Search CMDR |
9 | CMET INHIBITOR | 114364 | 0% | 100% | 1 | Search CMET+INHIBITOR | Search CMET+INHIBITOR |
10 | CYTOPLASMIC EFFECTORS | 114364 | 0% | 100% | 1 | Search CYTOPLASMIC+EFFECTORS | Search CYTOPLASMIC+EFFECTORS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | XU, XH , LIU, J , SHEN, CY , DING, LL , ZHONG, F , OUYANG, Y , WANG, YC , HE, S , (2017) THE ROLE OF UBIQUITIN-SPECIFIC PROTEASE 14 (USP14) IN CELL ADHESION-MEDIATED DRUG RESISTANCE (CAM-DR) OF MULTIPLE MYELOMA CELLS.EUROPEAN JOURNAL OF HAEMATOLOGY. VOL. 98. ISSUE 1. P. 4 -12 | 16 | 48% | 0 |
2 | DALTON, WS , HAZLEHURST, L , SHAIN, K , LANDOWSKI, T , ALSINA, M , (2004) TARGETING THE BONE MARROW MICROENVIRONMENT IN HEMATOLOGIC MALIGNANCIES.SEMINARS IN HEMATOLOGY. VOL. 41. ISSUE 2. P. 1-5 | 13 | 65% | 23 |
3 | MEADS, MB , GATENBY, RA , DALTON, WS , (2009) ENVIRONMENT-MEDIATED DRUG RESISTANCE: A MAJOR CONTRIBUTOR TO MINIMAL RESIDUAL DISEASE.NATURE REVIEWS CANCER. VOL. 9. ISSUE 9. P. 665 -A674 | 21 | 20% | 266 |
4 | ZHU, BB , ZHAO, L , ZHU, LT , WANG, H , SHA, YY , YAO, J , LI, ZY , YOU, QD , GUO, QL , (2012) OROXYLIN A REVERSES CAM-DR OF HEPG2 CELLS BY SUPPRESSING INTEGRIN BETA 1 AND ITS RELATED PATHWAY.TOXICOLOGY AND APPLIED PHARMACOLOGY. VOL. 259. ISSUE 3. P. 387-394 | 12 | 44% | 6 |
5 | MUTLU, P , URAL, AU , GUNDUZ, U , (2012) DIFFERENTIAL GENE EXPRESSION ANALYSIS RELATED TO EXTRACELLULAR MATRIX COMPONENTS IN DRUG-RESISTANT RPMI-8226 CELL LINE.BIOMEDICINE & PHARMACOTHERAPY. VOL. 66. ISSUE 3. P. 228-231 | 10 | 48% | 4 |
6 | ZHU, XH , MIAO, XB , WU, YX , LI, CS , GUO, Y , LIU, YS , CHEN, YL , LU, XY , WANG, YC , HE, S , (2015) ENO1 PROMOTES TUMOR PROLIFERATION AND CELL ADHESION MEDIATED DRUG RESISTANCE (CAM-DR) IN NON-HODGKIN'S LYMPHOMAS.EXPERIMENTAL CELL RESEARCH. VOL. 335. ISSUE 2. P. 216 -223 | 9 | 47% | 3 |
7 | HE, S , HUANG, YJ , WANG, YC , TANG, J , SONG, Y , YU, XF , MA, J , WANG, ST , YIN, HB , LI, QY , ET AL (2015) HISTAMINE-RELEASING FACTOR/TRANSLATIONALLY CONTROLLED TUMOR PROTEIN PLAYS A ROLE IN INDUCED CELL ADHESION, APOPTOSIS RESISTANCE AND CHENNORESISTANCE IN NON-HODGKIN LYMPHOMAS.LEUKEMIA & LYMPHOMA. VOL. 56. ISSUE 7. P. 2153 -2161 | 13 | 32% | 1 |
8 | NAKAGAWA, Y , NAKAYAMA, H , NAGATA, M , YOSHIDA, R , KAWAHARA, K , HIROSUE, A , TANAKA, T , YUNO, A , MATSUOKA, Y , KOJIMA, T , ET AL (2014) OVEREXPRESSION OF FIBRONECTIN CONFERS CELL ADHESION-MEDIATED DRUG RESISTANCE ( CAM- DR) AGAINST 5-FU IN ORAL SQUAMOUS CELL CARCINOMA CELLS.INTERNATIONAL JOURNAL OF ONCOLOGY. VOL. 44. ISSUE 4. P. 1376-1384 | 12 | 28% | 11 |
9 | NEFEDOVA, Y , LANDOWSKI, TH , DALTON, WS , (2003) BONE MARROW STROMAL-DERIVED SOLUBLE FACTORS AND DIRECT CELL CONTACT CONTRIBUTE TO DE NOVO DRUG RESISTANCE OF MYELOMA CELLS BY DISTINCT MECHANISMS.LEUKEMIA. VOL. 17. ISSUE 6. P. 1175-1182 | 12 | 32% | 147 |
10 | DALTON, WS , (2002) DRUG RESISTANCE AND DRUG DEVELOPMENT IN MULTIPLE MYELOMA.SEMINARS IN ONCOLOGY. VOL. 29. ISSUE 6. P. 21-25 | 8 | 57% | 25 |
Classes with closest relation at Level 1 |